# Umoja Biopharma funding rounds and investors

As of 14 Oct 2026, Umoja Biopharma has raised $100M across 1 verified round on record; latest: $100 million Series C led by DCVC Bio and Double Point Ventures, announced 14 Jan 2025.

Umoja Biopharma, a clinical-stage leader developing in vivo CAR T cell therapies.

Website: https://umoja-biopharma.com  
Page: https://fireround.dev/companies/umoja-biopharma.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-01-14 | Series C | $100 million | DCVC Bio, Double Point Ventures | Alexandria Venture Investments, ARK Invest, CaaS Capital, Cormorant Asset Management, Emerson Collective Investments managed by Yosemite, K2 HealthVentures, MPM Capital, Myeloma Investment Fund, Qiming Venture Partners USA, RTW Investments, SoftBank Vision Fund 2, University of Minnesota Endowment | [umoja-biopharma.com](https://www.umoja-biopharma.com/news/umoja-biopharma-announces-oversubscribed-100-million-series-c-financing-to-advance-in-vivo-car-t-pipeline-through-key-oncology-clinical-milestones), [fiercebiotech.com](https://www.fiercebiotech.com/biotech/umoja-secures-100m-series-c-bring-more-car-ts-clinic) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.